Prendio is a software company specializing in e-procurement solutions for the life sciences industry. Their platform is designed to streamline the procurement process for biotech companies, improving efficiency and reducing costs. Prendio offers a cloud-based platform for managing procurement workflows in biotech companies. Their platform simplifies tasks like approvals, order placement, and vendor management. Prendio helps biotech companies save time and money by automating procurement processes.

Prendio

🎄 Season’s Greetings from Prendio-BioProcure! 
As we reflect on the year, we’re proud to have supported incredible biotech innovations. Here's to a 2025 filled with breakthroughs and opportunities! 
💬 What’s your biggest biotech goal for the new year? 
#HappyHolidays #BiotechGoals 

 BioProcure and Prendio Appoint Eric Meizlish as New CEO 

 BioProcure and Prendio Announce Strategic Growth Investment From Primus Capital 

 Prendio and BioProcure Announce Formation of New Advisory Board 

 BioProcure/Prendio Named #1 Best Place To Work In Massachusetts By The Boston Globe 

📢 Exciting News! Cayman Chemical is now a Prendio Preferred Supplier! 

Cayman Chemical is a leading provider of high-quality biochemicals, analytical standards, assay kits, antibodies, proteins, and drug discovery services. Their extensive product offerings and expert services support a wide range of therapeutic areas, including cancer, inflammatory and infectious diseases, metabolic conditions, neurodegenerative disorders, as well as emerging therapies like psychedelics and lipid nanoparticles. 💡🚀 

With Cayman on Prendio, biotech companies can now: 
➤ Access a vast catalog of high-quality research tools 
➤ Leverage expert drug discovery and development services 
➤ Further streamline their procurement process 

Explore Cayman’s catalog at: https://hubs.li/Q02_gzBz0

#CaymanChemical #Prendio #Biotech #DrugDiscovery #LifeScience #PharmaResearch

Prendio-BioProcure Launches PrendioPay: Enabling Life Science Companies to Achieve Operational Excellence with a Complete Procure-to-Pay Solution - PR Newswire

 BioProcure and Prendio Announce Strategic Growth ... 

Read the new guest post from Prendio Preferred Supplier, INDIGO Biosciences, INC!

Discover how INDIGO is advancing diabetes and obesity therapeutics research with innovative GLP-1R and GIPR assays. These cutting-edge tools simplify research, deliver reproducible data in as little as 24 hours, and bridge the gap between in vitro studies and vivo applications. 

💡 Why focus on GLP-1R and GIPR? 
These receptors are key in metabolic research, regulating insulin, appetite, and lipid metabolism. INDIGO’s ready-to-use kits empower scientists to develop next-generation therapeutics with speed and precision. 

🔬 Whether it’s for type II diabetes or obesity treatments, these assays pave the way for breakthrough therapies. 

👉 Learn more: https://hubs.li/Q02-_FmC0

#MetabolicResearch #DrugDiscovery #LifeSciences #GLP1R #GIPR #Therapeutics #Innovation 

 

Prendio-BioProcure Strengthens Leadership Team with Four Strategic Appointments, Accelerating Innovation and Growth - PR Newswire

Is Bad Bunny a Phillies fan? A brief investigation. - Inquirer.com

📊 Unlock the hidden potential in your lab operations! 

In our latest blog post, Tyler Mizenko shares how Prendio-BioProcure helps biotech labs scale smarter by optimizing spend and uncovering inefficiencies. 

Read the full insights here: https://hubs.li/Q030pyj40

#BiotechInnovation #ScalingSmart 

Catch our 2025 predictions for biotech and life sciences now live on the blog. Thanks to Stephen M. Perry of Kymanox, Valerie Podbelski of Prendio, Tom Fagley of EisnerAmper and Longfellow Real Estate Partners for sharing your insights. Leave a comment below to add to the conversation! 

https://lnkd.in/ewuHXsJp

🚀 Planning for JPM Week? 

Get actionable insights from Tyler Mizenko on scaling biotech labs efficiently in our latest blog post. 
Don’t miss these strategies before the big event: https://hubs.li/Q030pt5K0

#JPM2025 #Biotech #ScalingSuccess

🚨 We’re headed to JPM Week! 🚨
 
Tyler Mizenko and Tucker MacLean will be on-site offering personalized lab spend analyses to help biotech founders uncover inefficiencies and scale effectively. 

Learn more in our latest blog post: https://hubs.li/Q030mj100
 
#JPM2025 #Biotech #ScalingScience 

We’re thrilled have Ignyte Bio as a Prendio Preferred Supplier! 🎉
Ignyte Bio offers well-characterized human immune cell products, including antigen-specific T cells (ASpecT), to support your research needs.

This partnership ensures that Prendio users have streamlined access to Ignyte Bio’s cutting-edge products and solutions, further enhancing efficiency and innovation in the life sciences.

Together, we’re making procurement faster, simpler, and more impactful for the scientific community. 🧪🔬

 Find them through the Prendio Platform or at: https://hubs.li/Q030gYVw0

Prendio-BioProcure and Portal Innovations Announce Strategic Partnership to Accelerate Life Science Innovation - PR Newswire

🚨 Last chance to register for today’s must-attend webinar: "Beyond the Pitch Deck: Informal Strategies to Maximize Your Impact at JPM!" 

Join our CRO, Tyler Mizenko, and a panel of experts as they share insider tips on how to stand out at JPM. You'll discover how to:   

🔗 Network with intention and build genuine partnerships.  
💡 Stay sharp and energized in a fast-paced environment.  
✨ Craft and maintain a personal brand that leaves a lasting impact. 

Whether you’re a founder, investor, or industry professional, this session will give you the tools to navigate JPM with confidence, clarity, and purpose. 

🎟️ Bonus: Attendees will gain exclusive first access to LaunchBio Inc.'s Innovators Social Hour during JPM week in January 2025 – don’t miss out on this amazing networking opportunity! 

👉 Register now and join us for an insightful conversation: https://hubs.li/Q02_18kJ0

 Prendio-BioProcure Launches PrendioPay: Enabling Life Science Companies to Achieve Operational Excellence with a Complete Procure-to-Pay Solution 

BioProcure and Prendio Appoint Eric Meizlish as New CEO - PR Newswire

BioProcure/Prendio Named #1 Best Place To Work In Massachusetts By The Boston Globe - Massachusetts Biotechnology Council

Prendio and Sister Company BioProcure Receive Equity Investment from Primus Capital - FinSMEs

 Skoon Energy Raises $5.6M in Series A Funding 

 Top Places to Work in MA 2023: BioProcure/Prendio in Woburn 


              Check us out--Schedule A Demo
            

Prendio and BioProcure Announce Formation of New Advisory Board - PR Newswire

Prendio

About: